BioPharm Insight Profiles MSDxContinue reading
Author Archive: AZBio
RiboMed and AIT Partner on Epigenetic Tests for Early Lung Cancer Detection
RiboMed and Austrian Institute of Technology Partner on Epigenetic Tests for Early Lung Cancer Detection, Sub-typing and Drug Response.Continue reading
New AdvaMed White Paper Affirms FDA’s 510(k) Change Guidance
Only Targeted Improvements NeededContinue reading
Brain Parasite Has Potential to Unlock Neurobiology Secrets
Dr. Anita Koshy sees a common and typically harmless brain parasite as a potential key to unlocking secrets of neurobiology that can be used to intervene in diseases such as Alzheimer’s and multiple sclerosis.Continue reading
Biotech Crops vs. Pests: Successes, Failures From the First Billion Acres
A new global assessment helps scientists explain why genetically modified crops have suppressed some pests for longer than a decade, while others adapted in a few years.Continue reading
CRITICAL PATH INSTITUTE ANNOUCES NEW CONSORTIUM EXECUTIVE DIRECTOR
Dr. John-Michael Sauer, a 15-year veteran of pharmaceutical research and development, will lead the Predictive Safety Testing ConsortiumContinue reading
AHA Moment: Branding The Biosciences in Arizona
Arizona is home to a leading “emerging bioscience sector”…yet for most non-Arizonans, and many residents of the state, the industry and its value as a scientific and economic contributor is still unrecognized. Continue reading
AZBio Members Stand Out in 40 Under 40
25% of this year’s 40 Under 40 come from AZBio Member CompaniesContinue reading
UA Research Determines Feasibility of Newborn Screening in Tucson
Research by UA medical student Lucy Han finds that implementing recommended pulse oximetry screening guidelines is feasible at Tucson’s elevation. Continue reading
Next-generation sequencing could emerge as new standard of testing in cancer research and care – analysis from BioPharm Insight
Need for more trained biostatisticians to understand genetic data
CUSTOM study is first completed prospective trial using genetic analysis alone to assign cancer treatment
TGen conducting advanced melanoma study evaluating genomic-sequencing guided treatment and outcomesContinue reading